SCHEMBL7745843

SCHEMBL7745843

O=C1/C(=N\OC(c2ccccc2)(c2ccccc2)c2ccccc2)c2ccncc2N1Cc1nc2ccccc2n1CCCCF

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.38
TSHR P16473 2/20 0.33
PTK2B Q14289 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
RAB9A P51151 3/20 0.32
TP53 P04637 3/20 0.32
NPC1 O15118 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MAPT P10636 4/20 0.31
USP2 O75604 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
ATM Q13315 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPK1 P28482 1/20 0.31
NOS3 P29474 1/20 0.30
NOS1 P29475 1/20 0.30
NOS2 P35228 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7741750 0.85 CYP3A4 (0.44) CYP3A4TSHRPTK2BMEN1KMT2A
SCHEMBL7745821 0.82 CYP3A4 (0.48) CYP3A4TSHRMEN1KMT2ARAB9A
SCHEMBL8363984 0.81 CYP3A4 (0.39) CYP3A4TSHRPTK2BMEN1KMT2A
SCHEMBL7741398 0.79 CYP3A4 (0.50) CYP3A4TSHRPTK2BMEN1KMT2A
SCHEMBL7746706 0.79 CYP3A4 (0.40) CYP3A4TSHRMEN1KMT2ARAB9A
SCHEMBL7741391 0.78 CYP3A4 (0.37) CYP3A4
SCHEMBL8363985 0.76 CYP3A4 (0.40) CYP3A4MEN1KMT2ARAB9ATP53
SCHEMBL7746104 0.74 TSHR (0.35) TSHRPTK2BMEN1KMT2ARAB9A
SCHEMBL7741649 0.73 RAB9A (0.40) TSHRPTK2BMEN1KMT2ARAB9A
SCHEMBL7746259 0.73 CYP3A4 (0.35) CYP3A4TSHRPTK2BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed